Serologicals, LINCO, NIST

Premium

Serologicals to Acquire LINCO for $75M to Expand Multiplexing Products Portfolio

Serologicals announced this week that it has made an agreement to acquire LINCO, a life sciences company that focuses on supplying research assays and test kits for the Luminex-based multiplexing platform and other immunoassays.

Under terms of the agreement, Serologicals will pay $64.5 million in cash for the LINCO business, which has 109 employees, plus an additional $10.3 million for the land and buildings currently occupied by LINCO in St. Louis, Mo.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

Wired reports that 23andMe is trying to bolster its outside collaborations.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.